In vitro cytotoxicity of biosynthesized titanium dioxide nanoparticles in human prostate cancer cell lines
Purpose: To establish a green method for production of titanium dioxide (TiO2) nanoparticles (NPs) using Cinnamomum tamala (C. tamala) leaf extract, and examine the in vitro cytotoxicity of the product in a human prostate cancer (D145) cell line. Methods: TiO2 NPs were synthesized by mixing 20 mL of C. tamala leaf extract with 0.1 M titanium dioxide (Ti(OH)2) (80 mL) in aqueous solution with stirring for 2 h at room temperature. The TiO2 NPs were characterized using x-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), x-ray photoelectron spectroscopy, dynamic light scattering (DLS), transmission electron microscopy (TEM), selected-area electron diffraction, and energy dispersive x-ray spectroscopy. The in vitro cytotoxicity against D145 cells was determined using a 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay. Results: TEM and DLS analyses showed that the NPs were irregularly shaped, with an average particle size of 23 nm. The FT-IR spectrum of C. tamala leaf extract showed that the biomolecules were potentially involved in reduction processes. The negative zeta potential of -14 mV indicated that the NPs were stable and discrete while their crystalline nature was confirmed by XRD. Cytotoxicity analysis showed that the TiO2 NPs exhibit a dose-dependent toxic effect on D145 cells. Conclusion: A facile and less expensive approach for the production of TiO2 NPs using C. tamala leaf extract has been developed. The TiO2 NPs showed dose-dependent cytotoxicity towards D145 cells.
Keywords: Anticancer activity, Cinnamomum tamala, Green synthesis, Prostate cancer, TiO2 nanoparticles
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.